Monopar Therapeutics Inc (MNPR)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M | -1.58M |
Pre Tax Income | -2.89M | -2.44M | -2.2M | -1.95M | -1.81M | -1.64M | -1.72M | -1.3M |
Net Income | -2.89M | -2.44M | -2.2M | -1.95M | -1.81M | -1.64M | -1.72M | -1.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M | -1.4M |
EBITDA | -2.91M | -2.53M | -2.33M | -2.07M | -1.91M | -1.72M | -1.79M | -1.58M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 122k | 0 | 0 | 0 |
Operating Income | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
Pre Tax Income | -16.56M | -3.3M | -4.23M | -6.32M | -9.1M | -10.5M | -8.4M |
Net Income | -16.56M | -3.23M | -4.23M | -6.31M | -9.1M | -10.5M | -8.4M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.782 | -0.347 | -0.399 | -0.551 | -0.723 | -0.811 | -0.565 |
EBIT | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
EBITDA | -16.6M | -3.4M | -4.32M | -6.41M | -9.13M | -10.54M | -8.83M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.